http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017327796-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5bc5292a07e34d16eb1d033a16d3aec3
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-604
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-603
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-602
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-608
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-606
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-605
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-727
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-1307
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2510-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0696
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-074
filingDate 2015-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82390791a737e201cc15f3ee8cf52303
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9f8933db89062bee73646ecb4b722ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ecb70b0f7487f75fe6e91b3c575d2bf1
publicationDate 2017-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2017327796-A1
titleOfInvention Induced pluripotent stem cell and method for producing the same
abstract The disclosure provides an episome comprising OCT4, KLF4, SOX2, cMYC, NANOG, LIN28, and NRSA2. Also disclosed is a method for producing an induced pluripotent stem (iPS) cell. The method comprises introducing an episome into a cell, wherein the episome comprises OCT4, KLF4, SOX2, cMYC, NANOG, LIN28, and NRSA2, and growing the cell under conditions to select for the presence of the episome. The method also comprises selecting a primary clone and growing the primary clone in a medium comprising a MEK inhibitor and a GSK3b inhibitor.
priorityDate 2014-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012301438-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID220401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400160
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399420
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400161
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226417528
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6480472
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399419
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID745
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8378
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID124886
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2832
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395503

Total number of triples: 41.